Process Validation of Pharmaceutical Ingredients
Robert A. Nash
Abstract
Robert A. Nash
Abstract
This chapter reviews the requirements of the U.S. Food and Drug Administration (FDA) for process validation of manufacturing pharmaceutical active ingredients (APIs) and inactive ingredients used in human and veterinary drug products.
OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
This chapter reviews the requirements of the U.S. Food and Drug Administration (FDA) for process validation of manufacturing pharmaceutical active ingredients (APIs) and inactive ingredients used in human and veterinary drug products.
Key concepts: Process validation, Process engineering, Process (computing), Computer science, Business, Engineering, New product development, Marketing